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Effect of beta adrenoceptor antagonists on baroreceptor 
reflex sensitivity in hypertension 
High-pressure baroreceptor reflex sensitivity (BRS) was estimated by measuring the reflex 
heart rate response to pharmacologic elevation olblood pressure (phenylephrine, 150 to 
200 f.Lg intravenously) in 18 patients with essential hypertension on two occasions: after a 
4-wk placebo period and after 9 wk of incremental doses of oral timolol (20, 40, and 60 
mg daily). On placebo, measurements were pelformed both before and after propranolol 
(0.2 mglkg intravenously). The level of cardiac vagal inhibition, estimated by the heart 
rate change alter atropine (0.04 mglkg intravenously), was similar on placebo and on 
timolol, thereby permitting comparisons of BRS. BRS on placebo (belore and after 
propranolol) correlated with BRS on timolol (r = 0.87 and 0.90, p < 0.001), attesting to 
the reproducibility of BRS measurements. BRS was unchanged by either short-term 
(propranolol) or long-term (timolof) beta adrenoceptor inhibition. Results were similar in 
responders (n = 10), whose mean arterial blood pressure on timolol fell by 10 mm Hg or 
more, and in nonresponders. The findings do not provide evidence for a change in gain of 
the baroreceptor reflex arc under conditions of short- or long-term beta adrenoceptor 
inhibition. 
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Despite the widespread use of beta ad-
renoceptor antagonists in the treatment of 
hypertension, the mechanism of their antihyper-
tensive action remains controversial. 12 It has 
been suggested that beta adrenoceptor an-
tagonists act by reducing cardiac responses to 
pressor stimuli; the attenuation of cardiac re-
sponses gradually condition (reset) the high-
pressure baroreceptors to regulate blood 
pressure at a lower level in hypertensive pa-
tients.14 The possibility that beta adrenoceptor 
antagonists decrease pressor responses by ip-
creasing baroreceptor reflex sensitivity also was 
suggested. H Baroreceptor reflex sensitivity has 
been tested in normal subjects after single intra-
venous injections of propranolol and in hyper-
tensive subjects receiving long-term proprano-
lol therapy,H, 13 In both cases, some increase in 
sensitivity was noted, but it did not reach statis-
tical significance in the hypertensive subjects. 
The number of subjects studied was small, 
Received for publication Jan. 10, 1977. 
Accepted for publication May 7, 1977. 
Reprint requests to: Geza Simon, M.D .• Veterans Administration 
Hospital (lIICI), 54th SI. and 48th Ave., Minneapolis, Minn. 
55417. 
Our study was designed for two purposes: (1) 
to measure the effect of short- and long-term 
administration of beta adrenoceptor antagonists 
on the baroreceptor reflex sensitivity of patients 
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Table I. Mean arterial blood pressure (MAP), heart rate (RR) , heart rate response to 
atropine (!::J.RR, atr), and baroreceptor slope (BRS) in 18 patients with essential hypertension on 
placebo before and after propranolol and after 9 wk of timolol therapy (means ± SEM) 
MAP HR t:.HR (atr) BRS 
Treatment (mm Mg) (beats/min) (beats/min) (msec/mm Hg) 
Placebo 
Rest 107 :±: 3.5 59:±: 2.0 13.6 :±: 2.06 
Propranolol 107 :±: 2.9 54 :±: 1.6* 35 :±: 4.0t 13.8 :±: 2.34 
(0.2 mg/kg intravenously) 
Timolol (60 mg/day) 98 :±: 3.4+ 48 :±: 1.4* 36 :±: 3.2t 14.2:±: 1.96 
*p < 0.001 by paired Student's t test for comparison with measurements obtained at rest on placebo. 
tn = 16. 
+p < 0.05 by paired Student's t test for comparison with measurements obtained at rest on placebo. 
with essential hypertension and (2) to test the 
hypothesis that an increase in baroreceptor 
reflex sensitivity contributes to the antihyper-
tensive action of beta adrenoceptor antagonists. 
The study is part of a more extensive investi-
gation of the antihypertensive properties of 
timolol maleate currently in progress at our in-
stitution. Timolol maleate is a pure beta in-
hibitor without membrane-stabilizing or sym-
pathomimetic activity. In its pharmacologic 
action timolol resembles propranolol, but on a 
weight for weight basis it is 5 to 10 times as 
potent as propranolol. 1, 2 
Materials and methods 
Our subjects were 18 men, aged 42 (range, 
23 to 56) yr, with uncomplicated mild or mod-
erate essential hypertension. Secondary causes 
of hypertension were excluded by clinical ex-
amination, rapid-sequence intravenous pyelog-
raphy, and laboratory studies (serum creatinine 
and electrolytes, urinalysis, and urinary epi-
nephrine and norepinephrine). 
All antihypertensive medications were dis-
continued and all subjects were given placebo, 
one tablet twice daily for 4 wk, followed by 
three consecutive 3-wk periods of incremental 
doses of timolol, 20, 40, and 60 mg daily, in 2 
divided doses. The subjects were seen at the 
end of the placebo period and at the end of each 
3-wk treatment period. Patient compliance was 
monitored by pill counts. No other cardiac or 
antihypertensive medications were given during 
the study. The subjects were studied on two 
occasions: after the 4-wk placebo period and at 
the end of the 9-wk treatment period when 
every subject had been taking 60 mg of timolol 
for at least 3 wk. 
Experiments were performed in the morning 
after a 24-hr hospital stay with the subjects 
fasted for 10 hr and in the supine position. The 
method of Smyth and co-workers l6 in which the 
reflex heart rate response to pharmacologic ele-
vation of the blood pressure is measured, was 
used to estimate the high-pressure baroreceptor 
reflex sensitivity. Brachial artery pressure was 
recorded via an intra-arterial catheter connected 
to a Statham P23Db transducer. Intra-arterial 
pressure was raised 20 to 40 mm Hg by intrave-
nous bolus injections of phenylephrine (150 to 
200 fLg) administered through a catheter in-
serted in an antecubital vein. Injections were 
performed in duplicate or triplicate. Arterial 
blood pressure and lead II of the electrocardio-
gram were recorded simultaneously on a 
Hewlett-Packard 4578A polygraph at 25 
mm/sec paper speed during and for 40 to 60 sec 
following the completion of the injections. Dur-
ing the first study, while the subjects were on 
placebo, the injections and the measurements 
were repeated 10 min after the administration of 
propranolol (0.2 mg/kg intravenously). 
The sensitivity of the high-pressure baro-
receptors of each subject was estimated by 
plotting the R-R interval from the electrocar-
diograph for each heartbeat against the systolic 
blood pressure of the preceding beat for 20 to 
30 sec, from the start of the rise of pressure to 
just before the peak pressure, by means of the 
techniques of Smyth and co-workers. 16 All 
beats during inspiration and expiration were in-
cluded into the calculations, a modification in-
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BARORECEPTOR SLOPE (msec/mm Hg) PLACEBO after PROPRANOLOL 
Fig. 1. Correlation of baroreceptor slope after short-term beta adrenoceptor inhibition with pro-
pranolol with baroreceptor slope after long-term timolol treatment in 18 patients with essential 
hypertension. 
troduced by Bristow and colleagues." The plot 
of R-R intervals: systolic blood pressures was 
analyzed for linear correlation. The reflex sen-
sitivity was expressed as the slope of the regres-
sion line. The slope was used for comparisons 
only if the r value (correlation coefficient) in an 
individual was greater than 0.60 and the p value 
was less than 0.05. Since duplicate or triplicate 
determinations in the same subject were aver-
aged, a sufficient number of readings was avail-
able and none of the study participants had to be 
excluded. 
Cardiac vagal inhibition was estimated by 
recording the heart rate change following the 
intravenous administration of atropine (0.04 
mg/kg).10 On placebo, the administration of at-
ropine followed short-term beta inhibition with 
intravenous propranolol. In patients on oral 
timolol (60 mg daily) atropine was administered 
following the completion of baroreceptor sen-
sitivity measurements. Cardiac vagal inhibition 
is expressed as the change in heart rate follow-
ing atropine (IlHR atr). 
Student's t test, the t test for paired obser-
vations, and correlation coefficients were cal-
culated by means of the Midas (Constat) 
Computer Program of the Statistical Research 
Laboratory at the University of Michigan. 
Results 
The average heart rates and mean arterial 
blood pressures and the average slopes of the 
regression lines, estimating baroreceptor reflex 
sensitivity, of 18 subjects on placebo and on 
timolol are summarized in Table I. 
A verage mean arterial blood pressure 
(107 ± 3.5 [mean ± SEM]) on placebo at rest 
was unaltered following short-term beta inhibi-
tion with propranolol (107 ± 2.9) but de-
creased after 9 wk of timolol therapy to 
98 ± 3.4 (p < 0.05). The average heart rate, 
which was 59 ± 2.0 beats/min at rest and 
54 ± 1.6 short-term after beta inhibition with 
propranolol (p < 0.001), was reduced fur-
ther by long-term timolol administration to 
48 ± 1.4 (p < 0.001). Cardiac vagal inhibi-
tion, estimated by the heart rate change follow-
ing the administration of atropine, was similar 
on placebo and on timolol. The average slopes 
of baroreceptor sensItIVIty, 13.6 ± 2.06 
msec/min, on placebo at rest was unaltered by 
either short-term (propranolol) or long-term 
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Table II. Mean arterial blood pressure (MAP), heart rate (RR) , and baroreceptor slope (BRS) of 
10 responders* and 8 nonresponders on placebo and timoLoL (means ± SEM) 
Placebo Timolol 
Parameter Responders I Nonresponders Responders I Nonresponders 
MAP (mm Hg) 
HR (beats/min) 
BRS (msec/mm Hg) 
III ± 3.8 
63 ± 2.5t 
13.3 ± 2.62 
102 ± 6.2 
55 ± 2.4 
13.9 ± 3.07 
92 ± 1.7t 
50 ± 1.8 
15.6±3.16 
106 ± 6.6 
47 ± 2.0 
12.4 ± 2.00 
*Defined as ~10 mm Hg fall in MAP on 60 mg of timolol. 
tp < 0.05 for comparison of measurements in responders and nonresponders. 
(timolol) beta inhibition. Baroreceptor sensitiv-
ity measurements in subjects on placebo before 
and after intravenous propranolol correlated 
with baroreceptor measurements on timolol 
(r = 0.87 and 0.90, p < 0.001), attesting to 
the reproducibility of these measurements (Fig. 
I) . 
The same data were analyzed in terms of 
blood pressure response to long-term timolol 
administration (Table II). In 10 patients, de-
fined as responders, mean arterial blood 
pressure was reduced by 10 mm Hg or more. In 
the remaining 8 nonresponders, mean arterial 
blood pressure was unchanged or increased. On 
placebo, the average resting heart rate of re-
sponders (63 ± 2.5) was higher than that of 
nonresponders (55 ± 2.4, p < 0.05). The dif-
ferences in heart rate were no longer significant 
after long- term timolol administration. Average 
pretreatment mean arterial blood pressure and 
baroreceptor sensitivity were similar in the two 
groups. Neither responders nor nonresponders 
experienced changed baroreceptor sensitivity 
after long-term timolol therapy. 
In these 18 patients with mild or moderate 
essential hypertension on placebo, baroreceptor 
sensitivity was inversely related to mean arterial 
blood pressure (r = 0.51, P < 0.05) and to age 
(r = 0.58, P < 0.05). There was no rela-
tionship between initial heart rate and baro-
receptor sensitivity (r = 0.01). 
Discussion 
The heart rate response following the intra-
venous injection of phenylephrine is reflex in 
origin, mediated via high-pressure barorecep-
tors, the contribution of low-pressure baro-
receptors being small. 11, 15 The reduction in 
heart rate can be measured precisely, unlike 
arterial dilatation, venous dilatation, and reduc-
tion in myocardial contractility, the other reflex 
effects of baroreceptor stimulation. These con-
siderations led Smyth and associates6 and 
Bristow and co-workers5 to develop their 
methods, used in our study, to estimate 
baroreceptor reflex sensitivity. The conclusions 
drawn with the use of their methods should be 
limited to the baroreceptor-mediated reflex con-
trol of heart rate. 
The early increase in R-R interval (bradycar-
dia) following a transient rise in blood pressure 
is predominantly parasympathetic. Sympathetic 
effects become more important after about 30 
sec. IS During the initial 30 sec, atropine (1.8 
mg intravenously) abolishes the heart rate re-
sponse to the blood pressure elevation. The lack 
of sympathetic involvement in the early heart 
response is demonstrated in our study; acute 
beta adrenoceptor inhibition with intravenous 
propranolol had no effect on baroreceptor reflex 
sensitivity. Our data are at variance with those 
of Pickering and co-workers l3 who found an 
increase in baroreceptor reflex sensitivity after 
intravenous propranolol in 4 of 5 normotensive 
subjects. The discrepancy between their find-
ings and ours may be due to the larger number 
of subjects studied by us or to differences in 
the response of hypertensive and normotensive 
subjects. Eckberg and associates6 measured the 
prolongation of the R-R intervals during electri-
cal stimulation of the carotid sinus nerve in pa-
tients who required baropacing for angina and 
found no change in reflex bradycardia following 
intravenous propranolol. 
Since the baroreceptor-mediated reflex bra-
dycardia as tested by the method of Smyth 
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and associates16 is predominantly parasympa-
thetic, the level of cardiac vagal inhibition at 
the time of testing may influence the degree of 
reflex bradycardia. 16 Accordingly, since vagal 
activity cannot be increased further, a high ini-
tial vagal tone would be associated with an at-
tenuated reflex bradycardia. In our study, vagal 
inhibition, as estimated by the heart rate re-
sponse to atropine, was similar on placebo and 
on timolol. 
The magnitude of reflex bradycardia follow-
ing a transient rise in blood pressure is also 
dependent on the age of the subject, the level of 
physical exercise, the presence or absence of 
cardiovascular disease, the initial heart rate, 
and the level of blood pressure.:3, 5. 7, 9. 17 For 
the purposes of our study which involved paired 
comparisons in the same individuals, the con-
tributions of initial heart rate and blood pressure 
are relevant. Finally, the question of the repro-
ducibility of the baroreceptor responses must be 
considered. 
In unanesthetized normotensive rabbits, 
Alexander and De Cuir:l noted a positive corre-
lation between initial heart rate and the mag-
nitude of reflex bradycardia. Initial heart rate 
had no effect on the reflex bradycardia of hyper-
tensive rabbits. Smyth and colleagues 16 found 
an opposite relationship between the initial 
heart rate and the reflex bradycardia in sleeping 
normal subjects; the steepest responses were 
recorded at the lowest resting heart rates. In our 
study, short-term beta adrenoceptor inhibition 
with propranolol reduced the heart rate. There 
was an additional decrease in heart rate follow-
ing long-term beta adrenoceptor inhibition with 
timolol. The degree of reflex slowing of heart 
rate in our subjects, however, was independent 
of the heart rate prior to the injection of phenyl-
ephrine. 
In human established and borderline essential 
hypertension the baroreceptor reflex sensitivity 
is decreased, although the basis for this is un-
clear. 7, 17 An inverse relationship between the 
severity of the hypertension and the reduction 
of baroreceptor reflex sensitivity was also noted 
by us as well as by others. 7. 17 Therefore, the 
initial blood pressure level or the level of blood 
pressure attained on treatment with timolol may 
influence the baroreceptor reflex sensitivity. 
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However, the baroreceptor reflex sensitivity of 
our nonresponders whose blood pressure did 
not change and of our responders whose blood 
pressure fell significantly was similar on both 
placebo and timolol. Differences in the absorp-
tion of the drug between the two groups is an 
unlikely explanation, because a similar degree 
of beta adrenoceptor inhibition judged by re-
sponses to isoproterenol and exercise was 
achieved in the two groups. * The lowering of 
blood pressure over a period of 2 mo in respon-
ders was not associated with an increase in 
baroreceptor reflex sensitivity. We found the 
method of Smyth and associates16 to be highly 
reproducible, as attested by the high degree of 
correlation obtained between measurements 
taken in the same subjects on 2 different days 
9 wk apart. 
Animal experiments suggest that the increase 
in baroreceptor reflex sensitivity involves the 
central nervous system. 4 The findings of our 
study do not provide evidence for a change in 
gain of the high-pressure baroreceptor reflex arc 
under conditions of short- or long-term beta 
adrenoceptor inhibition. Central sensitization of 
the baroreflex arc, such as that described for 
clonidine in animal experiments, does not seem 
to occur with the use of beta adrenoceptor an-
tagonists, such as timolol, in the treatment of 
hypertensive patients. 12 Unaltered cardiac vagal 
inhibition during therapy with timolol is addi-
tional evidence against a clinically significant 
central nervous system action of beta ad-
renoceptor antagonists. The antihypertensive 
action of beta adrenoceptor antagonists must be 
due to mechanisms other than the increased 
sensitivity of the high-pressure baroreceptor re-
flex. 
'Unpublished observations. 
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